vTv Therapeutics Inc sell tamam
Start price
18.04.18
/
50%
€2.07
Target price
31.05.18
€1.08
Performance (%)
-7.83%
End price
31.05.18
€1.91
Summary
This prediction ended on 31.05.18 with a price of €1.91. With a performance of -7.83%, the SELL prediction for vTv Therapeutics Inc by tamam was down slightly. tamam has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| vTv Therapeutics Inc | - | - | - | - |
| iShares Core DAX® | 0,05 % | 1,31 % | 11,38 % | 62,79 % |
| iShares Nasdaq 100 | 1,60 % | -0,90 % | 7,29 % | 90,94 % |
| iShares Nikkei 225® | 3,06 % | 12,95 % | 33,77 % | 70,77 % |
| iShares S&P 500 | 0,82 % | 0,70 % | 4,93 % | 61,76 % |
Comments by tamam for this prediction
In the thread vTv Therapeutics Inc diskutieren
vTv Therapeutics' azeliragon flunks late-stage Alzheimer's study
Bottom feeders have stampeded into fallen biotech vTv Therapeutics
(Vom Mitglied beendet)


